Newsweek (11/20, Dovey) reports that a study “suggests that in addition to being at higher risk of developing breast cancer, overweight women are more likely to have larger tumors at the time of diagnosis.” The findings are to be presented at the Radiological Society of North America meeting.
Medscape (11/16, Nelson) reports that the Food and Drug Administration approved for long-term use the SAVI Scout reflector, a wire-free, nonradioactive breast tumor localization device that is part of the SAVI Scout surgical guidance system made by Cianna Medical Inc. Medscape says, “The system uses an intratumoral electromagnetic wave device, implanted under ultrasound or mammographic guidance, to localize occult breast lesions with a probe during surgery.” The approval is important because “with the new FDA clearance, it can remain in place during the period between biopsy and surgery,” reducing the need for reexcision.
Aunt Minnie (11/10) reported that bipartisan legislation “that would standardize communication to women regarding whether they have dense breast tissue on mammography” has been “introduced in both the US House” and Senate. Among other things, the legislation “would set a minimum federal standard, as designated by the US Secretary of Health and Human Services (HHS), for notification about dense tissue and recommend that women discuss with their healthcare providers whether they would benefit from additional screening.”
Aunt Minnie (11/9) reports that “the American College of Radiology’s (ACR) expert panel on breast imaging has published appropriateness criteria for breast cancer screening.” The criteria were published in the Journal of the American College of Radiology.